AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Clinical trial NCT05522894 · UNKNOWN

Trial details

NCT number: NCT05522894
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Esophageal Squamous Cell Carcinoma Locally Advanced Esophageal Squamous Cell Carcinoma Metastatic Esophageal Squamous Cell Carcinoma

Start date: 2022-10-01
Primary completion: 2024-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.